Blastoma

Please enable JS and disable any ad blocker Read More

You're visiting this site from a location that is not currently supported. We are working on expanding access to usatoday.com and we appreciate your interest and patience. Read More

Collins suffered from glioblastoma, an aggressive form of brain cancer. Published May 12, 2026  •  Last updated 21 hours ago  •  1 minute read Jason Collins Photo by Jonathan Bachman /The Associated Press Jason Collins, the first active male athlete on a major U.S. sports team to live openly gay, has…

Skip to Main Content Boston Celtics Collins had been diagnosed with Stage 4 glioblastoma, which has an extremely low survival rate. He was 47. Jason Collins, who spent part of the 2012-13 season with the Celtics and was the first openly gay player in the NBA, died Tuesday at the…

May 12, 2026, 6:53 PM EDT / Updated May 13, 2026, 8:32 AM EDT Jason Collins, a longtime NBA center who became the first man to come out as openly gay while playing in any of America’s four leading professional sports leagues, died Tuesday following months of treatment for glioblastoma, his family said.…

Glioblastoma remains a highly challenging malignancy with a pronounced tendency for recurrence. The hypoxic microenvironment is a key contributor to its therapy resistance. Hyperbaric oxygen therapy (HBOT), which elevates tissue oxygen pressure and reverses hypoxia, exhibits a "dual effect" in glioblastoma management. On one hand, HBOT enhances radiosensitivity through reactive…

A team of researchers in Canada has identified a new way to slow the growth of glioblastoma, the most aggressive and currently incurable type of brain cancer, and they have also pointed to an existing drug that could potentially be used to treat it. The study reveals that some brain…

A new mouse study shows that a molecule in pig semen could have promising results for an eye cancer found in children. (Image credit: Fairfax Medivia Getty Images) Scientists have found a way to get treatment for a rare type of cancer into the back of the eye without damaging…

Proceedings of the National Academy of Sciences, Volume 123, Issue 13, March 2026.

Researchers from Mass General Brigham and Dana-Farber Cancer Institute report that a single dose of an oncolytic virus, a genetically engineered virus designed to infect and kill cancer cells, can draw immune cells deep into brain tumors and keep them active there. Their findings, published in Cell, explain how this…